Zacks Research Analysts Reduce Earnings Estimates for MMSI

Merit Medical Systems, Inc. (NASDAQ:MMSI) – Stock analysts at Zacks Research cut their Q3 2027 EPS estimates for Merit Medical Systems in a research note issued to investors on Friday, July 17th. Zacks Research analyst Team now forecasts that the medical instruments supplier will earn $0.97 per share for the quarter, down from their previous forecast of $0.98. The consensus estimate for Merit Medical Systems’ current full-year earnings is $3.62 per share. Zacks Research also issued estimates for Merit Medical Systems’ FY2027 earnings at $3.82 EPS and Q1 2028 earnings at $0.94 EPS.

A number of other research firms also recently commented on MMSI. Piper Sandler reiterated an “overweight” rating on shares of Merit Medical Systems in a research note on Friday, July 10th. Barrington Research reduced their target price on Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating on the stock in a report on Monday, April 20th. Needham & Company LLC decreased their target price on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Compass Point set a $107.00 target price on Merit Medical Systems in a research report on Monday, April 20th. Finally, Citigroup reiterated an “outperform” rating on shares of Merit Medical Systems in a report on Monday, April 20th. Eight research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Merit Medical Systems has an average rating of “Moderate Buy” and a consensus price target of $92.80.

Merit Medical Systems Stock Performance

Shares of Merit Medical Systems stock opened at $73.11 on Tuesday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 5.08. Merit Medical Systems has a 1 year low of $59.74 and a 1 year high of $94.75. The firm’s 50-day simple moving average is $67.72 and its 200-day simple moving average is $72.21. The firm has a market cap of $4.36 billion, a PE ratio of 31.65, a price-to-earnings-growth ratio of 2.29 and a beta of 0.52.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.10. The company had revenue of $381.88 million during the quarter, compared to analyst estimates of $377.59 million. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the business earned $0.86 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS.

Insider Activity

In related news, Director Lynne N. Ward sold 5,000 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $62.61, for a total transaction of $313,050.00. Following the completion of the sale, the director owned 7,809 shares of the company’s stock, valued at $488,921.49. This represents a 39.04% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Brian G. Lloyd acquired 2,000 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were acquired at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the purchase, the insider owned 2,000 shares of the company’s stock, valued at $125,240. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of MMSI. State Street Corp raised its stake in shares of Merit Medical Systems by 1.5% in the 4th quarter. State Street Corp now owns 2,231,048 shares of the medical instruments supplier’s stock worth $196,645,000 after buying an additional 32,459 shares in the last quarter. Conestoga Capital Advisors LLC boosted its stake in Merit Medical Systems by 3.9% during the first quarter. Conestoga Capital Advisors LLC now owns 2,167,513 shares of the medical instruments supplier’s stock valued at $149,407,000 after buying an additional 81,030 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its holdings in Merit Medical Systems by 12.7% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock worth $183,137,000 after acquiring an additional 234,682 shares during the period. Wellington Management Group LLP grew its holdings in Merit Medical Systems by 7.0% during the fourth quarter. Wellington Management Group LLP now owns 1,327,013 shares of the medical instruments supplier’s stock worth $116,963,000 after acquiring an additional 86,504 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in Merit Medical Systems by 1.0% in the first quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier’s stock worth $85,287,000 after acquiring an additional 12,285 shares in the last quarter. Institutional investors own 99.66% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.